Aarti Drugs Ltd.
AARTIDRUGS Share PricePharmaceuticals & Drugs
₹477.2
6.1 (1.3%)
As on September 8, 2025
Exchange Scrips: BSE524348NSEAARTIDRUGSISININE767A01016
Market Cap ₹ 4,354 Cr
P/E Ratio 25.59
Dividend Yield 0.02 %
Performance
Market performance
Open472.75
High478.95
Volumes1,17,862
Prev477.2
Low465
As on2025-09-08
Historical performance
1 Year High564.05
3 Year High645.75
5 Year High1,026.95
1 Year Low312
3 Year Low312
5 Year Low312
Fundamentals
Company Valuation
Market Cap (₹Cr)
4,354
Face Value (₹)
10
P/E Ratio
25.59
Dividend Yield
0.02 %
Investment Returns
1 Year
-13.8%
3 Years
2.4%
5 Years
-31.9%
10 Years
278.3%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 476.53 | Bullish |
| 10-DMA | 474.69 | Bullish |
| 20-DMA | 480.94 | Bearish |
| 50-DMA | 493.43 | Bearish |
| 100-DMA | 461.96 | Bullish |
| 200-DMA | 433.31 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 41 | 41 | 41 | 41 | 41 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 41 | 41 | 41 | 41 | 41 |
| Public Investors | 160219 | 169720 | 175965 | 190240 | 150177 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 25.59.
- 3Y Stock Price CAGR of the stock is 0.5.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹3249 Million.
- The company generated revenue of ₹25286 Million in the previous financial year.
Aarti Drugs Ltd.
477.26.1 (1.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 876319.9
No. of Shares: 1836 (Approx)
Performance:-12.4%
P/L: ₹-123680.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent